Akshaya Bio Inc. の製品パイプライン分析2016

Global Markets Directが発行した調査報告書(DATA70209173)
◆英語タイトル:Akshaya Bio Inc. - Product Pipeline Review - 2016
◆商品コード:DATA70209173
◆発行会社(リサーチ会社):Global Markets Direct
◆発行日:2016年10月12日
◆ページ数:29
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Site LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide (Global Site License)USD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Markets Direct社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Global Markets Direct社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Akshaya Bio Inc. – Product Pipeline Review – 2016
Summary

Global Markets Direct’s, ‘Akshaya Bio Inc. – Product Pipeline Review – 2016’, provides an overview of the Akshaya Bio Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Akshaya Bio Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Akshaya Bio Inc.
- The report provides overview of Akshaya Bio Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Akshaya Bio Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Akshaya Bio Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Akshaya Bio Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Akshaya Bio Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Akshaya Bio Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Akshaya Bio Inc. Snapshot 5
Akshaya Bio Inc. Overview 5
Key Facts 5
Akshaya Bio Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Akshaya Bio Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Pipeline Products – Combination Treatment Modalities 10
Akshaya Bio Inc. – Pipeline Products Glance 11
Akshaya Bio Inc. – Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Akshaya Bio Inc. – Drug Profiles 13
hepatitis C vaccine – Drug Profile 13
Product Description 13
Mechanism Of Action 13
R&D Progress 13
HIV vaccine – Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
influenza [strains A/H5N1 + A/H1N1] vaccine – Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
malaria vaccine – Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
NU-500 – Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Vaccine to Target CA9 for Cancer – Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
Vaccine to Target CEA for Oncology – Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Vaccine to Target HER 2/neu for Cancer – Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Vaccine to Target MUC1 for Oncology – Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Vaccine to Target PAP for Prostate Cancer – Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Westrern Equine Encephalitis Virus Vaccine – Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Akshaya Bio Inc. – Pipeline Analysis 24
Akshaya Bio Inc. – Pipeline Products by Target 24
Akshaya Bio Inc. – Pipeline Products by Molecule Type 26
Akshaya Bio Inc. – Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 28
Disclaimer 29

List of Tables
Akshaya Bio Inc., Key Facts 5
Akshaya Bio Inc. - Pipeline by Indication, 2016 7
Akshaya Bio Inc. - Pipeline by Stage of Development, 2016 8
Akshaya Bio Inc. - Monotherapy Products in Pipeline, 2016 9
Akshaya Bio Inc. - Combination Treatment Modalities in Pipeline, 2016 10
Akshaya Bio Inc. - Preclinical, 2016 11
Akshaya Bio Inc. - Discovery, 2016 12
Akshaya Bio Inc. - Pipeline by Target, 2016 25
Akshaya Bio Inc. - Pipeline by Molecule Type, 2016 26

List of Figures
Akshaya Bio Inc. - Pipeline by Top 10 Indication, 2016 7
Akshaya Bio Inc. - Pipeline by Stage of Development, 2016 8
Akshaya Bio Inc. - Monotherapy Products in Pipeline, 2016 9
Akshaya Bio Inc. - Pipeline by Top 10 Target, 2016 24
Akshaya Bio Inc. - Pipeline by Molecule Type, 2016 26

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Akshaya Bio Inc. の製品パイプライン分析2016(Akshaya Bio Inc. - Product Pipeline Review - 2016)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆